Moderna Vaccine Gets U.K. "Rolling Review"; Novavax Expands TrialsInvestors Business Daily • 10/27/20
Novavax's stock rises 3% as it announces plans to share Phase 2 vaccine data this weekMarket Watch • 10/27/20
Investors Betting on a Coronavirus Vaccine Better Know Who Gets First Dibs in Global PactThe Motley Fool • 10/27/20
What Are the Differences Between the Leading Coronavirus Vaccine Candidates?The Motley Fool • 10/25/20
Novavax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2020GlobeNewsWire • 10/20/20